Hellenic Association of Pharmaceutical Companies
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 17 Feb 2025 | Olga Solomon Head of Unit | Exchange of views on the reform of the General Pharmaceutical Legislation, discussion on the proposed system of incentives | — |
| 17 Feb 2025 | Olga Solomon Head of Unit | Exchange of views on the reform of the General Pharmaceutical Legislation, discussion on the proposed system of incentives | SRC |
| 08 Apr 2022 | Margaritis Schinas Vice-President | Pharma strategy in EU and Greece | SRC |
| 08 Apr 2022 | Margaritis Schinas Vice-President | Pharma strategy in EU and Greece | — |
| 01 Oct 2020 | Margaritis Schinas Vice-President | EU Health Policies | — |
| 01 Oct 2020 | Margaritis Schinas Vice-President | EU Health Policies | SRC |
| 29 Nov 2016 | Christos Stylianides Commissioner | exchange of vies on Pharmaceutical products distribution in refugee camps in Greece | — |
| 29 Nov 2016 | Christos Stylianides Commissioner | exchange of vies on Pharmaceutical products distribution in refugee camps in Greece | SRC |
Mission & Goals
The Hellenic Association of Pharmaceutical Companies (SFEE) represents one of the most innovative, productive, and extrovert sectors of the national economy. It encompasses more than 95% of the pharmaceutical industry operating in Greece. Its 63 member companies, national and multinational, are constantly investing in developing effective medicines and treatments to safeguard the right of all citizens to health and better quality of life. SFEE was established in 1982 and has championed the common interests of patients, pharmaceutical companies, and their workforce. Since 1983, SFEE has been a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the voice of the pharmaceutical industry at the European Union level. SFEE is also a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Europen Confederation of Pharmaceutical Entrepreneurs (EUCOPE).
EU Legislative Interests
- European Pharmaceutical Strategy - Green Deal & Environmental Policies - EU Industrial Strategy - EU Health Data Space - Review of the OMP and Paediatrics Regulations - European HTA - Council Presidencies - Patients' Access to healthcare - Cross-country collaborations - European Semester -Any other direct or indirect initiative affecting access to healthcare and pharmaceuticals
Communication Activities
-Publication of studies and reports in collaboration with external parties -Public policy events with stakeholders (policy debates, roundtable discussions, policy conferences) -Advocacy activities
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
SFEE is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) http://efpia.eu/ SFEE is a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) https://www.ifpma.org/ SFEE is a member of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) https://www.eucope.org/ SFEE is a member of the Hellenic Federation of Enterprises (SEV) http://www.sev.org.gr
Organisation Members
https://www.sfee.gr/en/sfee/members/
Additional Information
For our EU activities, we have not used or hired any intermediary to advance our interests over the last three years or currently ( at the time of the update).